Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C39H74O6 |
| Molecular Weight | 639.0013 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCC
InChI
InChIKey=VMPHSYLJUKZBJJ-UHFFFAOYSA-N
InChI=1S/C39H74O6/c1-4-7-10-13-16-19-22-25-28-31-37(40)43-34-36(45-39(42)33-30-27-24-21-18-15-12-9-6-3)35-44-38(41)32-29-26-23-20-17-14-11-8-5-2/h36H,4-35H2,1-3H3
| Molecular Formula | C39H74O6 |
| Molecular Weight | 639.0013 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs. | 2010-12 |
|
| Short chain saturated fatty acids decrease circulating cholesterol and increase tissue PUFA content in the rat. | 2010-11 |
|
| Myristate is selectively incorporated into surfactant and decreases dipalmitoylphosphatidylcholine without functional impairment. | 2010-11 |
|
| Characterization of an extracellular lipase from the biocontrol fungus, Nomuraea rileyi MJ, and its toxicity toward Spodoptera litura. | 2010-11 |
|
| Progress in antiretroviral drug delivery using nanotechnology. | 2010-08-09 |
|
| X-ray crystallographic and MD simulation studies on the mechanism of interfacial activation of a family I.3 lipase with two lids. | 2010-07-02 |
|
| Modeling the solid-liquid phase transition in saturated triglycerides. | 2010-02-07 |
|
| Pressure-induced phase transitions in triacylglycerides. | 2010-02 |
|
| Formation of biodegradable microcapsules utilizing 3D, selectively surface-modified PDMS microfluidic devices. | 2010-02 |
|
| Psoralea corylifolia Linn.-"Kushtanashini". | 2010-01 |
|
| Enzymatic preparation of structured oils containing short-chain fatty acids. | 2010 |
|
| Fatty acid selectivity of lipases during acidolysis reaction between oleic acid and monoacid triacylglycerols. | 2009-11-11 |
|
| Thermostable lipases from the extreme thermophilic anaerobic bacteria Thermoanaerobacter thermohydrosulfuricus SOL1 and Caldanaerobacter subterraneus subsp. tengcongensis. | 2009-09 |
|
| Influence of structural variations on drug release from lipid/polyethylene glycol matrices. | 2009-07-12 |
|
| Order-disorder phase transformation of triacylglycerols: effect of the structure of the aliphatic chains. | 2009-01-29 |
|
| Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution. | 2009-01 |
|
| Nanotechnology-based drug delivery systems. | 2007-12-01 |
|
| Isolation of lipase producing Bacillus sp. from olive mill wastewater and improving its enzyme activity. | 2007-11-19 |
|
| Some insights about 1,6-diphenyl-1,3,5-hexatriene-lipid supramolecular assemblies by steady-state fluorescence measurements. | 2007-09 |
|
| Effects of stereospecific positioning of fatty acids in triacylglycerol structures in native and randomized fats: a review of their nutritional implications. | 2007-07-12 |
|
| Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting. | 2007-04 |
|
| Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. | 2007 |
|
| Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms. | 2006-05-18 |
|
| Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver. | 2006-03 |
|
| Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles. | 2005-10-03 |
|
| Mutations in the "lid" region affect chain length specificity and thermostability of a Pseudomonas fragi lipase. | 2005-04-25 |
|
| Dialkylphosphatidylcholine and egg yolk lecithin for emulsification of various triglycerides. | 2005-04-10 |
|
| Raman spectroscopy investigation of various saturated monoacid triglycerides. | 2005-04 |
|
| Hydration of an amphiphilic excipient, Gelucire 44/14. | 2004-08-20 |
|
| Enzymatic synthesis of monolaurin. | 2004 |
|
| Maldigestion and malabsorption of dietary lipid during severe childhood malnutrition. | 2002-12 |
|
| Rapid thermogravimetric measurements of boiling points and vapor pressure of saturated medium- and long-chain triglycerides. | 2002-08 |
|
| Saturated triglycerides and fatty acids activate neutrophils depending on carbon chain-length. | 2002-04 |
|
| Process development for production of medium chain triglycerides using immobilized lipase in a solvent-free system. | 2002 |
|
| Final report on the safety assessment of trilaurin, triarachidin, tribehenin, tricaprin, tricaprylin, trierucin, triheptanoin, triheptylundecanoin, triisononanoin, triisopalmitin, triisostearin, trilinolein, trimyristin, trioctanoin, triolein, tripalmitin, tripalmitolein, triricinolein, tristearin, triundecanoin, glyceryl triacetyl hydroxystearate, glyceryl triacetyl ricinoleate, and glyceryl stearate diacetate. | 2001 |
|
| Fatty acids and derivatives as antimicrobial agents. | 1972-07 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:00:53 GMT 2025
by
admin
on
Mon Mar 31 19:00:53 GMT 2025
|
| Record UNII |
7FP2Z3RVUV
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000175273
Created by
admin on Mon Mar 31 19:00:53 GMT 2025 , Edited by admin on Mon Mar 31 19:00:53 GMT 2025
|
PRIMARY | |||
|
538-24-9
Created by
admin on Mon Mar 31 19:00:53 GMT 2025 , Edited by admin on Mon Mar 31 19:00:53 GMT 2025
|
PRIMARY | |||
|
4061
Created by
admin on Mon Mar 31 19:00:53 GMT 2025 , Edited by admin on Mon Mar 31 19:00:53 GMT 2025
|
PRIMARY | |||
|
1368880
Created by
admin on Mon Mar 31 19:00:53 GMT 2025 , Edited by admin on Mon Mar 31 19:00:53 GMT 2025
|
PRIMARY | RxNorm | ||
|
208-687-0
Created by
admin on Mon Mar 31 19:00:53 GMT 2025 , Edited by admin on Mon Mar 31 19:00:53 GMT 2025
|
PRIMARY | |||
|
C004565
Created by
admin on Mon Mar 31 19:00:53 GMT 2025 , Edited by admin on Mon Mar 31 19:00:53 GMT 2025
|
PRIMARY | |||
|
77389
Created by
admin on Mon Mar 31 19:00:53 GMT 2025 , Edited by admin on Mon Mar 31 19:00:53 GMT 2025
|
PRIMARY | |||
|
10851
Created by
admin on Mon Mar 31 19:00:53 GMT 2025 , Edited by admin on Mon Mar 31 19:00:53 GMT 2025
|
PRIMARY | |||
|
7FP2Z3RVUV
Created by
admin on Mon Mar 31 19:00:53 GMT 2025 , Edited by admin on Mon Mar 31 19:00:53 GMT 2025
|
PRIMARY | |||
|
DTXSID80904390
Created by
admin on Mon Mar 31 19:00:53 GMT 2025 , Edited by admin on Mon Mar 31 19:00:53 GMT 2025
|
PRIMARY | |||
|
7FP2Z3RVUV
Created by
admin on Mon Mar 31 19:00:53 GMT 2025 , Edited by admin on Mon Mar 31 19:00:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
